North America

CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination

The final policy affirms coverage across CareDx’s transplant surveillance offerings in kidney, heart, and lung...

Autonomous Healthcare receives FDA De Novo authorization for ventilator waveform software

Syncron-E detects evidence of ineffective patient efforts in ventilated adults, creating a new FDA device category for ventilator waveform analysis software....

ElectroWire Medical gains FDA clearance for transseptal puncture system

The LightningWire system is designed to support transseptal access in procedures such as atrial fibrillation ablation, left atrial appendage closure and transcatheter mitral interventions....

Co-Diagnostics completes studies for upper respiratory point-of-care PCR test

The company is preparing a dual FDA 510(k) and CLIA Waiver submission for its Flu A/B and RSV multiplex test on the Co-Dx PCR Pro platform....

AI Users in MedTech Sales 3x More Likely to Meet Quotas: AcuityMD Survey

AcuityMD surveyed 150 sales reps working across capital equipment and durable medical equipment (DME)...

ALZpath pTau217 Antibody Featured in 86 Studies at AAIC 2026

The antibody has been selected by Abbott, Beckman-Coulter Diagnostics, Roche, Siemens Healthineers, Alamar Biosciences, Bio-Techne and Quanterix for the development of research and clinical pTau217 assays...

Movmedix enters US market with FDA-cleared synthetic ligament system

The LARS ACJ clearance gives the French orthopaedic company a first US regulatory milestone for its synthetic ligament platform....

Johnson & Johnson gains FDA approval for dual-energy cardiac ablation platform

The integrated catheter platform allows electrophysiologists to deliver radiofrequency and pulsed field energy through a single device....

Cochlear introduces rechargeable Osia 3 sound processor in US

The FDA-cleared bone conduction sound processor adds rechargeable use, improved sound processing and wider streaming options for hearing implant users....

FDA Clears at-Home Weekly Leqembi Injection for Early Alzheimer's Disease

Leqembi Iqlik is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance...